The Tokyo-based company, newly formed by former employees of Illumina Japan, will use next-generation sequencing technology to analyze the vaginal and intra-uterine flora, e. g., in the context of in-vitro fertilization.
https://varinos.strikingly.com

Nikkei Biotech news release, July 31, 2017